Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose

European Journal of Gynaecological Oncology

Volumn 23, Issue 2, 2002, Pages 115-119

  Cerrotta, A ^a   Gardani, G ^a   Cavina, R ^a   Raspagliesi, F ^a   Stefanon, B ^a   Garassino, I ^a   Musumeci, R ^a   Tana, S ^a   De Palo, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cervical cancer; Paclitaxel; Radiosensitizer

Indexed keywords

CESIUM; PACLITAXEL; RADIOSENSITIZING AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLADDER DISEASE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; INOPERABLE CANCER; MUCOSA INFLAMMATION; PILOT STUDY; RADIATION DOSE; RADIOSENSITIVITY; RECURRENT CANCER; SMALL INTESTINE DISEASE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; CLINICAL TRIAL; DOSE RESPONSE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION RESPONSE; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PILOT PROJECTS; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 0036010345     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Investigation of taxol as a potential radiation sensitizer
2. Interaction with ionizing radiation
3. Taxol a novel radiation sensitizer
4. Taxol sensitizes human astrocytoma cells to radiation
5. Paclitaxel: A radiation sensitizer of human cervical cancer cells
6. Radiation and taxol effects on synchronized human cervical carcinoma cells
7. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines
8. Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors
9. Concurrent paclitaxel and thoracic radiation for advanced non-small cell lung cancer
10. Preliminary analysis of a phase Il study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer
11. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung
12. Paclitaxel by 1-hour infusion in combination chemotherapy of stage 111 non-small cell lung cancer
13. Phase I trial of Taxol as a radiation sensitizer with cisplatin in advanced cervical cancer
14. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri
15. Staging announcement: Figo staging of gynecologic cancers: Cervical and vulva
16. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. I. Analysis of tumor recurrence
17. Short-term persistence of carcinoma of the uterine cervix after radiation. An indicator of long-term prognosis
18. Improved treatment for cervical cancer. Concurrent chemotherapy and radiotherapy
19. Concurrent chemoradiation in advanced cervical cancer
20. Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer
21. Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma
22. Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery
23. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer
24. Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix
25. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies
26. A phase I-II trial of multimodality management of bulky gynecologic malignancy. Combined chemoradio-sensitization and radiotherapy
27. Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis in squamous cell carcinoma of the uterine cervix
28. Weekly cisplatin and radical therapy for advanced, recurrent, and poor prognosis cervical carcinoma
29. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix
30. Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix
31. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix
32. Preliminary results of concurrent radiotherapy and chemotherapy with cisplatinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: A pilot study
33. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
34. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
35. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Group study